Invesco Ltd. Has $37.23 Million Holdings in Surgery Partners, Inc. $SGRY

Key Points

• Invesco Ltd. reduced its stake in Surgery Partners, Inc. by 27.5% during the first quarter, now holding approximately 1.22% of the company, valued at $37.23 million.
• Several institutional investors made significant moves, with PNC Financial Services Group increasing its stake by 86.4% and GAMMA Investing LLC boosting its position by an extraordinary 7,902.7%.
• Surgery Partners recently reported a quarterly revenue increase of 8.4% year-over-year, with earnings per share of $0.17, slightly above analyst expectations.

Invesco Ltd. lowered its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 27.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,567,684 shares of the company's stock after selling 594,220 shares during the period. Invesco Ltd. owned about 1.22% of Surgery Partners worth $37,232,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of SGRY. PNC Financial Services Group Inc. lifted its holdings in shares of Surgery Partners by 86.4% during the first quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company's stock valued at $28,000 after acquiring an additional 542 shares during the period. DekaBank Deutsche Girozentrale acquired a new stake in shares of Surgery Partners in the 1st quarter valued at $65,000. State of Wyoming boosted its stake in shares of Surgery Partners by 94.4% in the 4th quarter. State of Wyoming now owns 4,002 shares of the company's stock valued at $85,000 after purchasing an additional 1,943 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. boosted its stake in shares of Surgery Partners by 12.1% in the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock valued at $91,000 after purchasing an additional 465 shares in the last quarter. Finally, GAMMA Investing LLC boosted its stake in shares of Surgery Partners by 7,902.7% in the 1st quarter. GAMMA Investing LLC now owns 8,883 shares of the company's stock valued at $211,000 after purchasing an additional 8,772 shares in the last quarter.

Surgery Partners Price Performance

NASDAQ SGRY traded up $0.78 on Friday, hitting $23.64. 1,273,842 shares of the company were exchanged, compared to its average volume of 1,777,135. The firm has a 50 day moving average of $22.13 and a two-hundred day moving average of $22.91. The company has a market cap of $3.03 billion, a P/E ratio of -16.53 and a beta of 1.82. The company has a current ratio of 1.93, a quick ratio of 1.78 and a debt-to-equity ratio of 1.10. Surgery Partners, Inc. has a 1-year low of $18.87 and a 1-year high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.01. The business had revenue of $826.20 million for the quarter, compared to the consensus estimate of $816.96 million. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The firm's quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.21 EPS. On average, equities analysts predict that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Insider Transactions at Surgery Partners

In other Surgery Partners news, Director Teresa Deluca sold 20,018 shares of the company's stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $22.74, for a total transaction of $455,209.32. Following the transaction, the director directly owned 45,173 shares in the company, valued at approximately $1,027,234.02. This represents a 30.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 2.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on SGRY shares. Barclays reduced their target price on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 27th. Bank of America started coverage on shares of Surgery Partners in a research note on Monday, July 28th. They issued a "buy" rating and a $28.00 target price on the stock. Six research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Surgery Partners has a consensus rating of "Moderate Buy" and an average target price of $33.00.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.